Trial intelligence / Profile preview

Impact of Topical Clobetasol on Gingival Crevicular Fluid miRNAs in Oral Lichen Planus

NCT05818618Completed

Sponsor
University of Catania
Start
Mar 2020
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in oral lichen planus (OLP) comparing Clobetasol propionate 0,05% gel with Placebo (2 arms). Primary endpoint: microRNAs Gingival Crevicular Fluid levels at 6 months. Started Mar 2020; status: completed.

02

Drugs

clobetasol
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on NCT05818618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05818618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call